*If any of the following: use of oral HIV PrEP or oral postexposure prophylaxis medications in the past 3 months, previously received cabotegravir or lenacapavir-SQ, had high-risk exposure to HIV in prior 4 weeks, or has signs/symptoms that suggest acute HIV infection.
^If the person receiving HIV PrEP is a woman with pregnancy potential
Abbreviations: eCrCL = estimated creatinine clearance; MSM = men who have sex with men; PWID = persons who inject drugs
Since you are not signed in, your progress won't be saved.
July 22nd, 2025